BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11301110)

  • 1. Soluble Kit receptor blocks stem cell factor bioactivity in vitro.
    Dahlen DD; Lin NL; Liu YC; Broudy VC
    Leuk Res; 2001 May; 25(5):413-21. PubMed ID: 11301110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen.
    Broudy VC; Lin NL; Priestley GV; Nocka K; Wolf NS
    Blood; 1996 Jul; 88(1):75-81. PubMed ID: 8704204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor.
    Broudy VC; Morgan DA; Lin N; Zsebo KM; Jacobsen FW; Papayannopoulou T
    Blood; 1993 Jul; 82(2):436-44. PubMed ID: 7687159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells.
    Erben U; Thiel E; Notter M
    Cancer Res; 1999 Jun; 59(12):2924-30. PubMed ID: 10383156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.
    Nakamura Y; Tajima F; Ishiga K; Yamazaki H; Oshimura M; Shiota G; Murawaki Y
    Exp Hematol; 2004 Apr; 32(4):390-6. PubMed ID: 15050750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit.
    Lennartsson J; Shivakrupa R; Linnekin D
    J Biol Chem; 2004 Oct; 279(43):44544-53. PubMed ID: 15308671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia.
    Pietsch T
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):285-6. PubMed ID: 7687773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
    Ito F; Toyota N; Sakai H; Takahashi H; Iizuka H
    Arch Dermatol Res; 1999 May; 291(5):275-83. PubMed ID: 10367710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines.
    Turner AM; Bennett LG; Lin NL; Wypych J; Bartley TD; Hunt RW; Atkins HL; Langley KE; Parker V; Martin F
    Blood; 1995 Apr; 85(8):2052-8. PubMed ID: 7536489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor.
    Broudy VC; Kovach NL; Bennett LG; Lin N; Jacobsen FW; Kidd PG
    Blood; 1994 Apr; 83(8):2145-52. PubMed ID: 7512842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
    Lantz CS; Huff TF
    J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of stem cell factor as a serum factor: monoclonal anti-c-kit antibody abrogates interleukin-6-dependent colony growth in serum-containing culture.
    Shiohara M; Koike K; Kubo T; Amano Y; Takagi M; Muraoka K; Nakao J; Nakahata T; Komiyama A
    Exp Hematol; 1993 Jul; 21(7):907-12. PubMed ID: 7686504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell line.
    Oez S; Hofmann-Wackersreuther G; Birkmann J; Smetak M; Welte K; Gallmeier WM
    Eur Cytokine Netw; 1993; 4(4):293-7. PubMed ID: 7505637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.
    Liesveld JL; Broudy VC; Harbol AW; Abboud CN
    Exp Hematol; 1995 Mar; 23(3):202-9. PubMed ID: 7533098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.
    Turner AM; Zsebo KM; Martin F; Jacobsen FW; Bennett LG; Broudy VC
    Blood; 1992 Jul; 80(2):374-81. PubMed ID: 1378316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat1 associates with c-kit and is activated in response to stem cell factor.
    Deberry C; Mou S; Linnekin D
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):73-80. PubMed ID: 9355737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.